1 |
Ottman, N., Huuskonen, L., Reunanen, J., Boeren, S., Klievink, J., Smidt, H., Belzer, C. and de Vos, W. M. 2016. Characterization of outer membrane proteome of Akkermansia muciniphila reveals sets of novel proteins exposed to the human intestine. Front. Microbiol. 7, 1157. doi: 10.3389/fmicb.2016.01157.
DOI
|
2 |
Tuohy, K. M. and Scott, K. P. 2015. "The microbiota of the human gastrointestinal tract: a molecular view" in diet-microbe interactions in the gut. pp. 1-15. Tuohy, K. M. and Del Rio, D. (eds.), Elsevier, London.
|
3 |
Ueno, N., Fujiya, M., Segawa, S., Nata, T., Moriichi, K., Tanabe, H., Mizukami, Y., Kobayashi, N., Ito, K. and Kohgo, Y. 2011. Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier. Infamm. Bowel. Dis. 17, 2235-2250.
DOI
|
4 |
Viana, S. D., Nunes, S. and Reis, F. 2020. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities-Role of gut microbiota dysbiosis. Ageing Res. Rev. 62, 101123. doi: 10.1016/j.arr.2020.101123.
DOI
|
5 |
Walker, A. W., Duncan, S. H., Louis, P. and Flint, H. J. 2014. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 22, 267-274.
DOI
|
6 |
Zhang, T., Li, Q., Cheng, L., Buch, H. and Zhang, F. 2019. Akkermansia muciniphila is a promising probiotic. Microb. Biotechnol. 12, 1109-1125.
DOI
|
7 |
Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C., Troost, F. J., Bork, P., Wels, M., de Vos, W. M. and Kleerebezem, M. 2012. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 6, 1415-1426.
DOI
|
8 |
Zolkiewicz, J., Marzec, A., Ruszczynski, M. and Feleszko, W. 2020. Postbiotics-a step beyond pre- and probiotics. Nutrients 12, 2189. doi: 10.3390/nu12082189.
DOI
|
9 |
Zuo, T., Liu, Q., Zhang, F., Lui, G. C., Tso, E. Y., Yeoh, Y. K., Chen, Z., Boon, S. S., Chan, F. K., Chan, P. K. and Ng, S. C. 2020. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 70, 276-284.
DOI
|
10 |
Turner, J. R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799-809.
DOI
|
11 |
Scheiman, J., Luber, J. M., Chavkin, T. A., MacDonald, T., Tung, A., Pham, L. D., Wibowo, M. C., Wurth, R. C., Punthambaker, S., Tierney, B. T., Yang, Z., Hattab, M. W., Avila-Pacheco, J., Clish, C. B., Lessard, S., Church, G. M. and Kostic, A. D. 2019. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104-1109.
DOI
|
12 |
Sanders, M. E., Lenoir-Wijnkoop, I., Salminen, S., Merenstein, D. J., Gibson, G. R., Petschow, B. W., Nieuwdorp, M., Tancredi, D. J., Cifelli, C. J., Jacques, P. and Pot, B. 2014. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann. N. Y. Acad. Sci. 1309, 19-29.
DOI
|
13 |
Reichardt, N., Duncan, S. H., Young, P., Belenguer, A., McWilliam, L. C., Scott, K. P., Flint, H. J. and Louis, P. 2014. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8, 1323-1335.
DOI
|
14 |
Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J. and Folkerts, G. 2016. The effects of short chain fatty acids on the cardiovascular system. Pharma. Nutr. 4, 68-111.
|
15 |
Ruiz, L., Delgado, S., Ruas-Madiedo, P., Sanchez, B. and Margolles, A. 2017. Bifidobacteria and their molecular communication with the immune system. Front. Microbiol. 8, 2345. doi: 10.3389/fmicb.2017.02345.
DOI
|
16 |
Schulz, E., Goes, A., Garcia, R., Panter, F., Koch, M., Muller, R., Fuhrmann, K. and Fuhrmann, G. 2018. Biocompatible bacteria-derived vesicles show inherent antimicrobial activity. J. Control. Release. 290, 46-55.
DOI
|
17 |
Singh, A., Vishwakarma, V. and Singhal, B. 2018. Metabiotics: the functional metabolic signatures of probiotics: current state-of-art and future research priorities-metabiotics: probiotics efector molecules. Adv. Biosci. Biotechnol. 9, 720-726.
|
18 |
Zhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., Pan, Y., Zhou, Q., Zhou, Y. and Yu, C. 2018. Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm. Bowel. Dis. 24, 1926-1940.
DOI
|
19 |
Sommer, F. and Backhed, F. 2013. The gut microbiota- masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238.
DOI
|
20 |
Song, H., Yoo, Y., Hwang, J., Na, Y. C. and Kim, H. S. 2016. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J. Allergy Clin. Immunol. 137, 852-860.
DOI
|
21 |
Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M. and Flint, H. J. 2003. Oligonucleotide probes that detect quantitatively significant groups of butyrate producing bacteria in human feces. Appl. Environ. Microbiol. 69, 4320-4324.
DOI
|
22 |
Nataraj, B. H., Ali, S. A., Behare, P. V. and Yadav, H. 2020. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb. Cell Fact. 19, 168. doi: 10.1186/s12934-020-01426-w.
DOI
|
23 |
Ahmadi Badi, S., Moshiri, A., Fateh, A., Rahimi Jamnani, F., Sarshar, M., Vaziri, F. and Siadat, S. D. 2017. Microbiota-derived extracellular vesicles as new systemic regulators. Front. Microbiol. 8, 1610. doi: 10.3389/fmicb.2017.01610.
DOI
|
24 |
Ashrafian, F., Behrouzi, A., Shahriary, A., Ahmadi Badi, S., Davari, M., Khatami, S., Rahimi Jamnani, F., Fateh, A., Vaziri, F. and Siadat, S. D. 2019. Comparative study of effect of Akkermansia muciniphila and its extracellular vesicles on toll-like receptors and tight junction. Gastroenterol. Hepatol. Bed. Bench. 12, 163-168.
|
25 |
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., de Vos, W. M. and Cani, P. D. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 110, 9066-9071.
DOI
|
26 |
Ashrafian, F., Shahriary, A., Behrouzi, A., Moradi, H. R., Keshavarz Azizi Raftar, S., Lari, A., Hadifar, S., Yaghoubfar, R., Ahmadi Badi, S., Khatami, S., Vaziri, F. and Siadat, S. D. 2019. Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery Vector for amelioration of obesity in mice. Front. Microbiol. 10, 2155. doi: 10.3389/fmicb.2019.02155. eCollection 2019.
DOI
|
27 |
Assimakopoulos, S. F., Triantos, C., Maroulis, I. and Gogos, C. 2018. The role of the gut barrier function in health and disease. Gastroenterol. Res. 11, 261-263.
DOI
|
28 |
Brodmann, T., Endo, A., Gueimonde, M., Vinderola, G., Kneifel, W., de Vos, W. M., Salminen, S. and Gomez-Gallego, C. 2017. Safety of novel microbes for human consumption: practical examples of assessment in the European Union. Front. Microbiol. 8, 1725. doi: 10.3389/fmicb.2017.01725.
DOI
|
29 |
Belkaid, Y. and Hand, T. W. 2014. Role of the microbiota in immunity and inflammation. Cell 157, 121-141.
DOI
|
30 |
Mantziari, A., Salminen, S., Szajewska, H. and Malagon-Rojas, J. N. 2020. Postbiotics against pathogens commonly involved in pediatric infectious diseases. Microorganisms 8, 1510. doi: 10.3390/microorganisms8101510.
DOI
|
31 |
Konig, J., Wells, J., Cani, P. D., Garcia-Rodenas, C. L., Macdonald, T., Mercenier, A., Whyte, J., Troost, F. and Brummer, R. J. 2016. Human intestinal barrier function in health and disease. Clin. Transl. Gastroenterol. 7, e196. doi: 10.1038/ctg.
DOI
|
32 |
Miquel, S., Beaumont, M., Martin, R., Langella, P., Braesco, V. and Thomas, M. 2015. A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb. Cell Fact. 14, 48. doi: 10.1186/s12934-015-0229-1.
DOI
|
33 |
O'Toole, P. W., Marchesi, J. R. and Hill, C. 2017. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 25, 17057. doi: 10.1038/nmicrobiol.2017.57.
DOI
|
34 |
Pique, N., Berlanga, M. and Minana-Galbis, D. 2019. Health benefts of heat-killed (Tyndallized) probiotics: an overview. Int. J. Mol. Sci. 20, 2534. doi: 10.3390/ijms20102534.
DOI
|
35 |
Foligne, B., Daniel, C. and Pot, B. 2013. Probiotics from research to market: the possibilities, risks and challenges. Curr. Opin. Microbiol. 16, 284-292.
DOI
|
36 |
Behrouzi, A., Vaziri, F., Rad, F. R., Amanzadeh, A., Fateh, A., Moshiri, Khatami, S. and Siadat, S. D. 2018. Comparative study of pathogenic and non-pathogenic Escherichia coli outer membrane vesicles and prediction of host-interactions with TLR signaling pathways. BMC Res. Notes 11, 539. doi: 10.1186/s13104-018-3648-3.
DOI
|
37 |
Moreno-Indias, I., Cardona, F., Tinahones, F. J. and Queipo-Ortuno, M. I. 2014. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front. Microbiol. 5, 190. doi: 10.3389/fmicb.2014.00190.
DOI
|
38 |
Cani, P. D. and de Vos, W. M. 2017. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8. 1765. doi:org/10.3389/fmicb.2017.01765
DOI
|
39 |
Derrien, M., Vaughan, E. E., Plugge, C. M. and de Vos, W. M. 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469-1476.
DOI
|
40 |
DeWeerdt, S. 2018. How baby's first microbes could be crucial to future health. Nature 555, S18-S19.
DOI
|
41 |
Graf, D., Di Cagno, R., Fak, F., Flint, H. J., Nyman, M., Saarela, M. and Watzl, B. 2015. Contribution of diet to the composition of the human gut microbiota. Microb. Ecol. Health Dis. 26, 26164. doi: 10.3402/mehd.v26.26164.
DOI
|
42 |
Huang, X. L., Zhang, X., Fei, X. Y., Chen, Z. G., Hao, Y. P., Zhang, S., Zhang, M. M., Yu, Y. Q. and Yu, C. G. 2016. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation. World J. Gastroenterol. 22, 5201-5210.
DOI
|
43 |
Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T. and Zhang, C. 2019. Alteration of gut microbiota in inflammatory bowel disease(IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8, 126. doi: 10.3390/pathogens8030126.
DOI
|
44 |
Rajilic-Stojanovic, M., Biagi, E., Heilig, H. G., Kajander, K., Kekkonen, R. A., Tims, S. and de Vos, W. M. 2011. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801.
DOI
|
45 |
Martens, E. C., Neumann, M. and Desai, M. S. 2018. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457-470.
DOI
|
46 |
Bag, S., Ghosh, T. S. and Das, B. 2017. Faecalibacterium prausnitzii isolated from the gut of a healthy indian adult. Genome Announc. 5, doi:10.1128/genomeA.01286-17. PMC 5690339. PMID 29146862.
DOI
|
47 |
Belzer, C. and de Vos, W. M. 2012. Microbes inside-from diversity to function: the case of Akkermansia. ISME J. 6, 1449-1458.
DOI
|
48 |
Delgado, S., Cabrera-Rubio, R., Mira, A., Suarez, A. and Mayo, B. 2013. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb. Ecol. 63, 763-772.
|
49 |
Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S. and Amedei, A. 2019. Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan postbiotics in inflammatory bowel disease. Front. Immunol. 10, 2754. doi: 10.3389/fimmu.2019.02754. eCollection 2019.
DOI
|
50 |
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N. and Duparc, T. 2017. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107-113.
DOI
|
51 |
Toyofuku, M., Nomura, N. and Eberl, L. 2019. Types and origins of bacterial membrane vesicles. Nat. Rev. Microbiol. 17, 13-24.
DOI
|
52 |
Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J. P., Ugarte, E., Munoz-Tamayo, R., Paslier, D. L., Nalin, R., Dore, J. and Leclerc, M. 2009. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584.
DOI
|
53 |
Soverini, M., Turroni, S., Biagi, E., Quercia, S., Brigidi, P., Candela, M. and Rampelli, S. 2017. Variation of carbohydrate-active enzyme patterns in the gut microbiota of Italian healthy subjects and Type 2 Diabetes Patients. Front. Microbiol. 8, 2079. doi: 10.3389/fmicb.2017.02079.
DOI
|
54 |
The human microbiome project consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214.
DOI
|
55 |
Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F. and Stanton, C. 2016. Gut microbiota, obesity and diabetes. Postgrad. Med. J. 92, 286-300.
DOI
|